|
Adlin EV, Maurer AH, Marks
AD, Channick BJ. Bone mineral density in postmeno-pausal women
treated with L-thyroxine. Am J Med 199;90:360-366
Affinito P, Sorrentino C, Farace MJ, di Carlo C, Moccia G, Canciello P, Palomba S, Nappi C. Effects of thyroxine therapy on bone metabolism in postmenopausal women with hypothyroidism. Acta Obstet Gynecol Scand 1996;75:843-848 Baran DT, Braverman LE. Thyroid hormones and bone mass. J Clin Endocrinol Metab 1991;72:1182-1183. Britto JM, Fenton AJ, Holloway WR, Nicholson GC. Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 1994;134:169-176 Campos-Pastor MM, Munoz-Torres M, Escobar-Jimenez F, Ruiz de Almodovar M, Jodar Gimeno E. Bone mass in females with different thyroid disorders: influence of menopausal status. Bone Miner 1993;21:1-8 Diamond T, Vine J, Smart R, Butler P. Thyrotoxic bone disease in women: a potentially reversible disorder. Ann Intern Med 1994;120:8-11 Editorial. Thyroxin replacement therapy: too much of a good thing? Lancet 1990;336:1352-1353 Eriksen EF, Mosekilde L, Melsen F. Kinetics of trabecular bone resorption and formation in hypothyroidism. Evidence for a positive balance per remodeling cycle. Bone 1986; 7:101-108 Eriksen EF, Mosekilde L, Melsen F. Trabecular bone remodeling and bone balance in hyperthyroidism. Bone 1985;6:421-428 Faber J, Galloe AM. Changes in bone mass during prolonged subclinical hyperthy-roidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 1994;130:3-50-356 Faber J, Jensen IW, Petersen L, Nygaard B, Hegedus L, Siersbaek-Nielsen K. Normaliza-tion of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroi-dism: effect on bone loss in postmenopausal women. Clin Endocrinol 1998; 48:28-5-290 Foldes J, Tarjan G, Szathmari M, Varga F, Krasznai I, Horvath C. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis? Clin Endocrinol 1993;39:521-527 Franklyn J, Betteridge J, Holder R, Daykin J, Lilley J, Sheppard M. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis. Clin Endocrinol 1994;41:425-432 Franklyn JA, Betterridge J, Daykin J, Holder R, Oates GD, Parle JV, Lilley J, Heath DA, Sheppard MC. Long-term thyroxin treatment and bone mineral density. Lancet 1992;340:9-13 Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J, Boyle P. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 1998 12;338:712-718 Grant DJ, McMurdo ME, Mole PA, Paterson CR, Davies RR. Suppressed TSH levels secondary to thyroxine replacement therapy are not associated with osteoporosis. Clin Endocrinol 1993;39:529-533 Grant DJ, McMurdo ME, Mole PA, Paterson CR. Is previous hyperthyroidism still a risk factor for osteoporosis in post-menopausal women? Clin Endocrinol 1995;43:339-345 Guo CY, Weetman AP, Eastell R. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Clin Endocrinol 1997;46:-301-307 Hanna FW, Pettit RJ, Ammari F, Evans WD, Sandeman D, Lazarus JH. Effect of replacement doses of thyroxine on bone mineral density. Clin Endocrinol 1998; 48:229--234 Jodar E, Munoz-Torres M, Escobar-Jimenez F, Quesada M, Luna JD, Olea N. Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism. J Clin Endocrinol Metab 1997;82:1989-1994 Jodar E, Munoz-Torres M, Escobar-Jimenez F, Quesada-Charneco M, Lund del Castillo JD. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause. Clin Endocrinol 1997;47:279-285 Jodar Gimeno E, Munoz-Torres M, Escobar-Jimenez F, Quesada Charneco M, Luna del Castillo JD, Olea N. Identification of metabolic bone disease in patients with endogenous-hyperthyroidism: role of biological markers of bone turnover. Calcif Tissue Int 1997;61:370-376 Langdahl BL, Loft AG, Eriksen EF, Mosekilde L, Charles P. Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy. Eur J Endocrinol 1996;134:702-709 Langdahl BL, Loft AG, Eriksen EF, Mosekilde L, Charles P. Bone mass, bone turnover, calcium homeostasis, and body composition in surgically and radioiodine-treated former hyperthyroid patients. Thyroid 1996; 6:169-175 Lee MS, Kim SY, Lee MC, Cho BY, Lee HK, Koh CS, Min HK. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J Clin Endocrinol Metab 1990;70:766-770 Leese GP, Jung RT, Guthrie C, Waugh N, Browning MC. Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol 1992;37:500-503 Lehmke J, Bogner U, Felsenberg D, Peters H, Schleusener H. Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women. Clin Endocrinol 1992;36:511-517 Mudde AH, Houben AJ, Nieuwenhuijzen Kruseman AC. Bone metabolism during anti-thy-roid drug treatment of endogenous subclinical hyperthyroidism. Clin Endocrinol 1994;41:421-424 Lupoli G, Nuzzo V, Di Carlo C, Affinito P, Vollery M, Vitale G, Cascone E, Arlotta F, Mudde AH, Reijnders FJ, Kruseman AC. Peripheral bone density in women with untreated multinodular goitre. Clin Endocrinol 1992;37:35-39 Nappi C. Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole. Gynecol Endocrinol 1996;10:34-3-348 Ribot C, Tremollieres F, Pouilles JM, Louvet JP. Bone mineral density and thyroid hormone therapy. Clin Endocrinol 1990;33:143-153 Rosen CJ, Adler RA. Longitudinal changes in lumbar bone density among thyrotoxic pa-tients after attainment of euthyroidism. J Clin Endocrinol Metab 1992;75:15-31-1534 Rosen HN, Moses AC, Gundberg C, Kung VT, Seyedin SM, Chen T, Holick M, Greenspan L. Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans. J Clin Endocrinol Metab 1997;77:664-669 Ross DS. Bone density is not reduced during the short-term administration of levothy-roxi-ne to postmenopausal women with subclinical hypothyroidism: a randomized, prospective study. Am J Med 1993;95:385-388 Schneider DL, Barrett-Connor EL, Morton MA. Thyroid hormone use and bone mineral density in elderly women. JAMA 1994;271:1234-1249 Solomon BL, Wartofsky L, Burman KD. Prevalence of fractures in postmenopausal women with thyroid disease. Thyroid 1993;3:17-23 Stall GM, Harris S, Sokoll LJ, Dawson-Hughes B. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med 1990 15;113:265-269 Suwanwalaikorn S, Baran D. Thyroid hormone and the skeleton. From Osteoporosis, Academic Press Inc. 1997; 855-861 Toh SH, Brown PH. Bone mineral content in hypothyroid male patients with hormone replacement: a 3-year study. J Bone Miner Res 1990;5:463-467 Toh SH, Claunch BC, Brown PH. Effects of hyperthyroidism and its treatment on bone mineral content. ARch Intern Med 1985;145:883-886 Von Recklinghausen FC. Die fibrose oder deformierende Ostitis, die Osteomalazie und die osteoplastische Carzinose in ihren gegenseitigen Beziehungen. In: Festschrift Rudolph Virchow. Berlin: Reiner, 1891:20-89 Wakasugi M, Wakao R, Tawata M, Gan N, Koizumi K, Onaya T. Bone mineral density in patients with hyperthyroidism measured by dual energy X-ray absorptiometry. Clin Endocrinol 1993;38:283-286 |
